Reporting to the Senior Director, FP&A, the Director of FP&A will support G&A, Global Medical Affairs, and Operations at Scholar Rock. The ideal candidate will have a strong track record of planning and delivering against financial objectives in partnership with cross-functional stakeholders. This person will also serve as a strategic partner, helping frame decisions, evaluate options, and drive value creation. Success in this role requires effective communication, organization, and collaboration skills. It is an excellent opportunity to help build a critical cross-functional capability at a growing biotechnology company with multiple product candidates.
Position Responsibilities
- Serve as the primary finance partner for G&A leadership, Global Medical Affairs and Operations
- Support for all FP&A activities including budgeting/forecasting, long-range planning, scenario modeling, and financial analysis for strategic initiatives
- Coordinate with accounting on month-end and quarterly close tasks, procure-to-pay processes, preparation of quarterly schedules, and support of external reporting and related audit inquiries
- Prepare timely monthly budget-to-actual analyses, including variance reporting and results summaries.
- Drive accountability for G&A leadership, Global Medical Affairs and Operations spending with regular business reviews with functional heads
- Strive for continuous improvement of FP&A processes, with the goal of improving efficiency while maintaining flexibility to adapt to future business needs
- Develop and deliver training programs and support change management efforts to drive adoption of new FP&A tools, systems, and ways of working across the organization
- Support ad hoc strategic initiatives as opportunities arise and capabilities expand, including business development analysis, partner support, and financing strategy.
- Leverage technology to driver efficiencies in the finance function
- Assist with developing Board of Directors and Executive Level materials
Candidate Requirements
- Bachelor’s degree with 8+ years of progressive finance experience in a pharmaceutical or biotechnology environment
- Advanced degree in finance and/or business preferred
- Prior experience supporting G&A functions in a cross-functional environment
- Excellent presentation skills to deliver information effectively across all levels of the organization
- Strong partnering and communication skills with the ability to distill financial information into a concise and actionable message
- Advanced Excel skills to perform complex analyses that support key decision-making
- Knowledge of fundamental accounting principles
- Strong organizational and critical thinking skills with the ability to manage multiple projects at one time
- Experience with Adaptive Insights and/or SAP considered an asset
Skills Required
- Bachelor's degree with 8+ years of progressive finance experience in a pharmaceutical or biotechnology environment
- Advanced degree in finance and/or business preferred
- Prior experience supporting G&A functions in a cross-functional environment
- Excellent presentation skills to deliver information effectively across all levels of the organization
- Strong partnering and communication skills with the ability to distill financial information into a concise and actionable message
- Advanced Excel skills to perform complex analyses that support key decision-making
- Knowledge of fundamental accounting principles
- Strong organizational and critical thinking skills with the ability to manage multiple projects at one time
- Experience with Adaptive Insights and/or SAP considered an asset
What We Do
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn. For additional information on our guidelines, please visit https://scholarrock.com/community-guidelines/ For more information on how Scholar Rock collects, uses, and shares personal information, please visit: https://scholarrock.com/privacy-policy
